Table 3 Ranking variables of treatment choices
From: The families evaluation on management, care and disclosure for terminal stage cancer patients
Expectance of survival | Expected Effectiveness | Complications Side-effects | Consequences in sexuality | Patient's Choice | Short term QoL | Long term QoL | |
|---|---|---|---|---|---|---|---|
Choices | |||||||
1st | 41 (28%) | 24(16%) | 4 (3%) | 0 | 18(12%) | 8 (5.5%) | 27(18.5%) |
2nd | 20 (14%) | 41 (28%) | 5 (3%) | 0 | 11(7.5%) | 20(13.5%) | 27(18.5%) |
3rd | 20 (14%) | 27(18.5%) | 17(12%) | 0 | 18(12%) | 12 (8%) | 28 (19%) |
4th | 23 (16%) | 12 (8%) | 26(18%) | 4 (3%) | 17(11.5%) | 31 (21%) | 11(7.5%) |
5th | 5 (3%) | 17(11.5%) | 30 (20.5%) | 2 (1%) | 24(16%) | 28(19%) | 17(11.5%) |
6th | 12 (8%) | 2 (1%) | 34 (23%) | 26(18%) | 28(19%) | 14 (9.5%) | 7 (5%) |
7th | 3 (2%) | 0 | 6 (4%) | 92 (63%) | 8 (5.5%) | 11 (7.5%) | 4 (3%) |
missing | 22 (15%) | 22(15%) | 22(15%) | 22 (15%) | 22(15%) | 22(15%) | 22(15%) |